4DMedical revenue and financials
In the fiscal year ended June 2026, 4DMedical reported revenue of $7.06M (+20.64% year over year). The net loss was $204.44M.
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +20.64%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- -2,895.1%
- FY to Jun 2025: -513.7%
How 4DMedical is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 114.2% a year on average over the last 3 years
Compound annual growth rate: from $718.58K in 2023 to $7.06M in 2026.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2026.
Operating margin rose from −6,202.5% to −813.7%
Operating income over revenue, 2023 → 2026: 5,388.8 percentage points.
Shares outstanding up 98.1% in 3 years
Average diluted shares, 2023 → 2026: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2022–2026.
Financial data
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Total revenue | 7.1 | 5.9 | 3.8 | 0.7 | 1.1 |
| Cost of revenue | 0.4 | 0.5 | 0.2 | 0.0 | 0.8 |
| Gross profit | 6.6 | 5.4 | 3.5 | 0.7 | 0.3 |
| Selling, general and administrative | 39.2 | 32.1 | 27.8 | 23.7 | 19.2 |
| Research and development | — | 0.9 | 0.7 | 4.0 | — |
| Operating income | -57.5 | -47.5 | -45.0 | -44.6 | -36.8 |
| EBIT | -57.5 | -47.5 | -45.0 | -44.6 | -36.8 |
| EBITDA | -56.0 | -46.0 | -43.9 | -43.8 | -36.3 |
| Interest expense | 167 | 0.3 | 0.3 | 0.3 | 0.2 |
| Pre-tax income | -206 | -30.2 | -35.9 | -31.1 | -24.5 |
| Income tax | -1.1 | -0.1 | 0.0 | 0.3 | 0.0 |
| Net income | -204 | -30.1 | -36.0 | -31.5 | -24.6 |
| Net income to common shareholders | -204 | -30.1 | -36.0 | -31.5 | -24.6 |
| Basic EPS | -0.38 | -0.07 | -0.10 | -0.10 | -0.08 |
| Diluted EPS | -0.38 | -0.07 | -0.11 | -0.10 | -0.08 |
| Average shares (basic) | 537 | 424 | 370 | 300 | 295 |
| Average shares (diluted) | 594 | 521 | 370 | 300 | 318 |
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.2 | 2.9 | 3.0 | 2.9 | 3.0 | 0.8 | 0.2 | 0.5 | 0.9 | 0.2 |
| Cost of revenue | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.7 | 0.1 |
| Gross profit | 4.0 | 2.7 | 2.7 | 2.7 | 2.8 | 0.7 | 0.2 | 0.5 | 0.2 | 0.1 |
| Selling, general and administrative | 20.8 | 18.4 | 16.9 | 15.2 | 15.8 | 12.0 | 12.9 | 10.8 | 10.3 | 8.9 |
| Operating income | -30.9 | -26.5 | -24.0 | -23.5 | -21.5 | -23.6 | -22.3 | -22.3 | -19.7 | -17.1 |
| EBIT | -30.9 | -26.5 | -24.0 | -23.5 | -21.5 | -23.6 | -22.3 | -22.3 | -19.7 | -17.1 |
| EBITDA | -30.7 | -25.3 | -25.1 | -20.9 | -21.8 | -22.0 | -22.8 | -21.0 | -19.8 | -16.5 |
| Interest expense | 28.4 | 139 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 |
| Pre-tax income | -50.5 | -155 | -18.9 | -11.3 | -20.4 | -15.6 | -14.9 | -16.2 | -12.1 | -12.5 |
| Income tax | -0.2 | -0.9 | -0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | — |
| Net income | -50.3 | -154 | -18.8 | -11.3 | -20.4 | -15.6 | -15.2 | -16.2 | -12.1 | -12.5 |
| Net income to common shareholders | -50.3 | -154 | -18.8 | -11.3 | -20.4 | -15.6 | -15.2 | -16.2 | -12.1 | -12.5 |
| Basic EPS | -0.09 | -0.31 | -0.04 | -0.03 | -0.06 | -0.04 | -0.05 | -0.06 | -0.04 | -0.04 |
| Diluted EPS | -0.09 | -0.31 | -0.04 | -0.03 | -0.07 | -0.04 | -0.05 | -0.06 | -0.04 | -0.04 |
| Average shares (basic) | 578 | 496 | 485 | 364 | 369 | 372 | 305 | 295 | 278 | 311 |
| Average shares (diluted) | 693 | 496 | 678 | 364 | 369 | 372 | 305 | 295 | 324 | 311 |
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Total assets | 365 | 94.8 | 120 | 92.9 | 74.3 |
| Current assets | 290 | 17.1 | 39.1 | 78.5 | 58.9 |
| Cash and equivalents | 278 | 6.9 | 30.6 | 69.6 | 51.1 |
| Receivables | 9.5 | 7.4 | 5.9 | 7.0 | 6.4 |
| Inventory | 0.2 | 0.9 | 1.0 | 0.7 | 0.0 |
| Net property, plant and equipment | 6.9 | 7.5 | 8.7 | 9.3 | 10.4 |
| Goodwill | 42.7 | 42.7 | 42.7 | — | — |
| Other intangible assets | 22.4 | 23.9 | 25.6 | 1.0 | 1.0 |
| Current liabilities | 9.4 | 19.3 | 21.9 | 16.2 | 9.6 |
| Accounts payable | 1.1 | 1.9 | 2.1 | 2.9 | 1.8 |
| Long-term debt | 177 | — | — | — | — |
| Total debt | — | 4.3 | 5.1 | 5.1 | 6.2 |
| Total liabilities | 195 | 30.6 | 49.1 | 21.5 | 14.8 |
| Total equity (incl. minority) | 170 | 64.2 | 70.9 | 71.5 | 59.5 |
| Retained earnings | -387 | -182 | -152 | -116 | -84.6 |
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 365 | 140 | 94.8 | 102 | 120 | 144 | 92.9 | 65.5 | 74.3 | 77.4 |
| Current assets | 290 | 63.6 | 17.1 | 22.7 | 39.1 | 61.7 | 78.5 | 50.2 | 58.9 | 68.3 |
| Cash and equivalents | 278 | 56.8 | 6.9 | 16.0 | 30.6 | 47.9 | 69.6 | 45.7 | 51.1 | 60.2 |
| Receivables | 9.5 | 3.1 | 7.4 | 3.5 | 5.9 | 10.3 | 7.0 | 2.6 | 6.4 | 5.9 |
| Inventory | 0.2 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 0.7 | 0.0 | 0.0 | 0.6 |
| Net property, plant and equipment | 6.9 | 6.6 | 7.5 | 7.9 | 8.7 | 8.4 | 9.3 | 9.9 | 10.4 | 4.6 |
| Goodwill | 42.7 | 42.7 | 42.7 | 42.7 | 42.7 | 68.1 | — | — | — | — |
| Other intangible assets | 22.4 | 23.1 | 23.9 | 24.7 | 25.6 | 1.6 | 1.0 | 0.9 | 1.0 | 0.7 |
| Current liabilities | 9.4 | 9.7 | 19.3 | 22.1 | 21.9 | 33.9 | 16.2 | 17.5 | 9.6 | 5.3 |
| Accounts payable | 1.1 | 3.2 | 1.9 | 5.5 | 2.1 | 7.3 | 2.9 | 14.9 | 1.8 | 3.0 |
| Long-term debt | 177 | 6.5 | — | — | — | — | — | — | — | — |
| Total debt | — | — | 4.3 | — | — | — | — | — | — | — |
| Total liabilities | 195 | 168 | 30.6 | 42.2 | 49.1 | 52.6 | 21.5 | 22.1 | 14.8 | 6.2 |
| Total equity (incl. minority) | 170 | -28.4 | 64.2 | 59.9 | 70.9 | 91.1 | 71.5 | 43.4 | 59.5 | 71.1 |
| Retained earnings | -387 | -336 | -182 | -163 | -152 | -132 | -116 | -101 | -84.6 | -72.5 |
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -31.3 | -34.5 | -30.9 | -22.7 | -25.3 |
| Depreciation and amortization | 2.3 | 2.3 | 2.1 | 1.7 | 1.5 |
| Capital expenditure | -0.9 | -0.1 | -0.2 | -0.4 | -2.6 |
| Investing cash flow | -2.4 | -1.6 | -40.0 | -1.6 | -3.5 |
| Financing cash flow | 305 | 12.4 | 31.9 | 42.7 | -1.0 |
| Share repurchases | — | -1.4 | — | -2.5 | — |
| Debt issued | 10.0 | — | — | 1.3 | — |
| Net change in cash | 271 | -23.7 | -39.0 | 18.5 | -29.8 |
| Free cash flow | -32.2 | -34.6 | -31.0 | -23.1 | -27.9 |
| Levered free cash flow | -136 | -27.7 | -17.0 | -20.5 | -26.2 |
Amounts in millions of AUD; per-share values in AUD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -18.6 | -12.7 | -20.3 | -14.1 | -16.1 | -14.7 | -17.6 | -5.0 | -7.6 | -17.6 |
| Depreciation and amortization | 1.1 | 1.2 | -0.2 | 2.6 | 0.6 | 1.5 | 0.5 | 1.2 | 1.0 | 0.5 |
| Capital expenditure | -0.8 | -0.1 | -0.0 | -0.0 | -0.1 | -0.1 | -0.3 | -0.1 | -0.5 | -2.1 |
| Investing cash flow | -1.6 | -0.8 | -0.8 | -0.8 | -0.7 | -39.4 | -0.6 | -1.1 | -0.8 | -2.7 |
| Financing cash flow | 241 | 63.4 | 12.0 | 0.3 | -0.5 | 32.4 | 42.0 | 0.7 | -0.6 | -0.4 |
| Debt issued | — | 10.0 | — | — | — | — | — | 1.3 | — | — |
| Debt repaid | -0.5 | -0.6 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.4 |
| Net change in cash | 221 | 49.9 | -9.1 | -14.7 | -17.3 | -21.7 | 23.8 | -5.4 | -9.1 | -20.7 |
| Free cash flow | -19.4 | -12.8 | -20.4 | -14.2 | -16.2 | -14.8 | -17.9 | -5.2 | -8.1 | -19.8 |
| Levered free cash flow | -35.6 | -100 | -17.1 | -10.6 | -17.3 | 0.3 | -18.2 | -2.4 | -7.8 | -18.5 |
Financial statements of similar companies
Companies in the group: same industry, similar size
